跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,771 条关于
“nicotinic acetylcholine receptor”
全部
13,771
临床试验
7,387
药物
1,357
机构
30
资讯
4,997
去年
Neuphoria Advances Dual Clinical Programs with Merck Partnership Milestone and Phase 3 SAD Trial Progress
2个月前
Neuphoria Confirms Merger Talks with Scancell as UK Biotech Eyes Nasdaq Listing
10个月前
Neuphoria Therapeutics Receives $5.20 Per Share Acquisition Offer from Lynx1 Master Fund Following Phase III Trial Failure
去年
Neuphoria Therapeutics Completes Phase 3 Enrollment for BNC-210 Social Anxiety Disorder Treatment
去年
Rapport Therapeutics Gains Buy Recommendation Based on RAP Platform and RAP-219 Potential
去年
Suven Life Sciences' Ropanicant Shows Positive Phase 2a Results for Major Depressive Disorder
去年
Achieve Life Sciences Completes Enrollment in Phase 3 ORCA-OL Trial for Cytisinicline
去年
Bionomics Advances BNC210 Phase 3 Trial for Social Anxiety Disorder and Strategic Partnership with Merck
去年
Achieve Life Sciences Completes Enrollment in ORCA-OL Trial and Receives FDA Breakthrough Therapy Designation for Cytisinicline
去年
BNC210 Shows Promise in Phase IIb Trial for PTSD Treatment
第 1 页，共 500 页
上一页
下一页
